Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea

OBJECTIVE: It has been established that use of proton pump inhibitors (PPIs) is associated with an increased risk of acquiring Clostridium difficile-associated diarrhoea (CDAD). However, it is not known whether the use of PPIs or histamine-2 receptor antagonists (H2RAs) concurrently with CDAD-target...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMJ Open Gastroenterol
Main Authors: Weiss, Karl, Louie, Thomas, Miller, Mark A, Mullane, Kathleen, Crook, Derrick W, Gorbach, Sherwood L
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2015
Assuntos:
Colon
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599152/
https://ncbi.nlm.nih.gov/pubmed/26462279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2014-000028
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares